Clinical Trials Logo

Clinical Trial Summary

Background:

- P. falciparum, one of the most virulent forms of malaria, causes more than 300 million episodes of malaria and 1 million deaths each year. The spread of drug-resistant parasites, insecticide-resistant mosquitoes, and persistent socioeconomic conditions of poverty compound the difficulties of malaria as a major global health problem. New means of disease and vector control are vitally needed.

- Several promising strategies rely on targeting mosquito populations when they are most vulnerable, such as during the dry season when mosquitoes find it difficult to reproduce. Large regions of the West African country of Mali have prolonged dry seasons (up to 8 months), during which mosquito populations dramatically decline within a month after the rainfall ceases. Clearly, mosquitoes can survive the dry season (as evident from their robust numbers during the wet season) but the process that enables them to do so remains unknown. Targeting the small and fragile mosquito population at the end of the dry season could reduce or eliminate the numbers of mosquitoes in certain regions, providing great benefits for communities in dry regions.

Objectives:

- To determine if common malaria-carrying mosquitoes survive the dry season in the Mali village of Thierola by estivation (going dormant, or hibernating, during dry periods).

- To identify and examine mosquitoes that were marked with special paint during a previous protocol, if these marked mosquitoes are captured during the investigation.

Eligibility:

- All activities in this protocol will take place in Thierola village, Banamba district, Koulikoro region, Mall, West Africa. The village was chosen because it is isolated from other communities by at least 6 km and is a small community of less than 300 inhabitants living in 90 houses.

- Participants will be healthy adult men between 18 and 65 years of age.

Design:

- Thirty adult men who live in Thierola will be recruited to participate as mosquito collectors for the human-baited trapping method and will work in teams of two.

- The first collector will expose his lower legs to attract human-seeking mosquitoes. Using a mouth aspirator, the second collector will collect the mosquitoes as they land on the first collector's legs.

- The collections will be conducted both indoors and outdoors from 6 p.m. to 6 a.m. the following morning for 14 consecutive days.

- All study volunteers will be trained in proper collection technique and supervised throughout the study by a mobile team led by the study investigators. Volunteers will be monitored for signs of malaria and treated accordingly if they develop symptoms of the disease.

- Researchers will collect mosquito samples at the end of the dry season (April-May) and at the start of the rainy season (May-June).

- Mosquitoes collected in the study will be analyzed by NIH researchers to learn more about how they survive during the dry season.


Clinical Trial Description

Malaria causes over one million deaths annually. A promising control strategy relies on targeting mosquito populations when they are vulnerable, such as during the dry season. Prolonged dry season during which larval sites are scarce and mosquito populations decline prevail in the Sahel which covers a large part of Mali. How mosquitoes withstand the dry season remains unknown. Some evidence supports the adult estivation hypothesis whereby mosquitoes remain in protected sites, except for sporadic journeys to obtain blood-meals to sustain themselves rather than to produce eggs. Alternatively, mosquitoes do not survive the dry season locally; rather, they migrate from areas where reproduction continues at permanent water bodies. We aim to determine if An. Gambiae estivate during the dry season in the Sahel; and if so, identify their hidden resting sites. As mosquito populations decline, standard sampling techniques yield zero mosquitoes. Because estivating females take blood meals intermittently, the most promising sampling technique is by human landing catch (HLC). Finding a few mosquitoes during the dry season have been reported, but it could not be determined if they were estivating or were migrants from villages, where larval sites persist. This study can resolve this because we captured marked and released over 5000 mosquitoes just before the dry season (November 2008). We aim to collect mosquitoes during the end of the dry season (April 2009) and the onset of the rainy season (June 2009) and find out if they bear marks from the previous wet season. Finding a single marked specimen will be the ultimate proof for the estivation hypothesis. Experiments will take place in the Sahelian village Thierola, Koulikoro Region, Mali, where the dry season exceeds 7 months. The village was chosen because it has no permanent larval sites and is a small community (< 300 inhabitants) living in 90 houses, allowing collection in all houses in a single day. Thirty adult male residing in Thierola will be recruited as collectors for the HLC. A collector will expose his lower legs to attract mosquitoes. Using a mouth aspirator, mosquitoes will be collected as they land on the collector's legs, ideally, before a blood meal is taken. Collection will be conducted 6pm to 6am for 14 consecutive days in April 2009 and again after the rains begin in June 2009. Collectors will be informed of the proper collecting procedures during the consenting procedure. During the time of year we propose to conduct this work, mosquito populations will be at their minima and any surviving mosquitoes will take blood meals infrequently. Therefore, the HLCs will be conducted when malaria transmission is extremely low and the risk to volunteers essentially nil. In summary, knowledge of how mosquitoes survive the dry season would open novel ways for vector and malaria control. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00863408
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase N/A
Start date March 3, 2009
Completion date March 10, 2010

See also
  Status Clinical Trial Phase
Completed NCT04601714 - Baseline Cohort Malaria Morbidity Study
Withdrawn NCT04020653 - A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria Phase 2
Terminated NCT04368910 - Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria Phase 3
Completed NCT03641339 - Defining Skin Immunity of a Bite of Key Insect Vectors in Humans N/A
Completed NCT02544048 - Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
Completed NCT00527163 - Role of Nitric Oxide in Malaria
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Active, not recruiting NCT04704674 - Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
Completed NCT03276962 - Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age Phase 2
Completed NCT04966871 - Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults Phase 1
Completed NCT00289185 - Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants Phase 2
Recruiting NCT03937817 - Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Active, not recruiting NCT06153862 - Africa Ready Malaria Screening N/A
Completed NCT04545905 - Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
Recruiting NCT06278181 - Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
Completed NCT02793622 - Prevention of Malaria in HIV-uninfected Pregnant Women and Infants Phase 3
Completed NCT02909712 - Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania Phase 2
Withdrawn NCT02793414 - Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
Withdrawn NCT02793388 - A Trial on Supervised Primaquine Use in Ethiopia Phase 4
Completed NCT02527005 - A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients Phase 1